Kenneth S. Boger

2007

In 2007, Kenneth S. Boger earned a total compensation of $2.1M as Senior Vice President and General Counsel at Vertex Pharmaceuticals, a 24% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$116,952
Option Awards$1,013,210
Salary$387,675
Stock Awards$580,922
Other$12,415
Total$2,111,174

Boger received $1M in option awards, accounting for 48% of the total pay in 2007.

Boger also received $117K in non-equity incentive plan, $387.7K in salary, $580.9K in stock awards and $12.4K in other compensation.

Rankings

In 2007, Kenneth S. Boger's compensation ranked 2,209th out of 8,700 executives tracked by ExecPay. In other words, Boger earned more than 74.6% of executives.

ClassificationRankingPercentile
All
2,209
out of 8,700
75th
Division
Manufacturing
750
out of 3,314
77th
Major group
Chemicals And Allied Products
146
out of 746
80th
Industry group
Drugs
78
out of 546
86th
Industry
Pharmaceutical Preparations
60
out of 364
84th
Source: SEC filing on April 8, 2009.

Boger's colleagues

We found four more compensation records of executives who worked with Kenneth S. Boger at Vertex Pharmaceuticals in 2007.

2007

Joshua Boger

Vertex Pharmaceuticals

Chief Executive Officer

2007

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2007

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2007

Kurt Graves

Vertex Pharmaceuticals

Executive Vice President, Chief Commercial Officer and Head, Strategic Development

You may also like